Ian F. Smith

2013

In 2013, Ian F. Smith earned a total compensation of $4.2M as EVP & Chief Financial Officer at Vertex Pharmaceuticals, a 35% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$682,500
Option Awards$2,361,640
Salary$582,959
Stock Awards$544,988
Other$12,675
Total$4,184,762

Smith received $2.4M in option awards, accounting for 56% of the total pay in 2013.

Smith also received $682.5K in non-equity incentive plan, $583K in salary, $545K in stock awards and $12.7K in other compensation.

Rankings

In 2013, Ian F. Smith's compensation ranked 1,639th out of 12,286 executives tracked by ExecPay. In other words, Smith earned more than 86.7% of executives.

ClassificationRankingPercentile
All
1,639
out of 12,286
87th
Division
Manufacturing
540
out of 4,614
88th
Major group
Chemicals And Allied Products
145
out of 1,466
90th
Industry group
Drugs
97
out of 1,160
92nd
Industry
Pharmaceutical Preparations
85
out of 890
90th
Source: SEC filing on April 29, 2016.

Smith's colleagues

We found four more compensation records of executives who worked with Ian F. Smith at Vertex Pharmaceuticals in 2013.

2013

Jeffrey Leiden

Vertex Pharmaceuticals

Chief Executive Officer

2013

Stuart Arbuckle

Vertex Pharmaceuticals

EVP & Chief Commercial Officer

2013

Kenneth Horton

Vertex Pharmaceuticals

Chief Legal Officer

2013

Peter Mueller

Vertex Pharmaceuticals

Chief Scientific Officer

News

In-depth

You may also like